Evidence map›Paper›PMID 41418299›Full record

ReviewJMIR dermatology2025

Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review.

Finn Abeck, Inga Hansen-Abeck, Julian Kött, Edward Garrahy, Stefan W Schneider, Johannes von Büren

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JMIR dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Finn AbeckDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, 20251, Germany, 49 15222837104.ORCID 0000-0001-7823-0736
Inga Hansen-AbeckDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, 20251, Germany, 49 15222837104.ORCID 0009-0007-5579-4337
Julian KöttDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, 20251, Germany, 49 15222837104.ORCID 0000-0003-2073-3909
Edward GarrahyWellster Healthtech Group, Munich, Germany.ORCID 0009-0005-8642-6946
Stefan W SchneiderDepartment of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, 20251, Germany, 49 15222837104.ORCID 0000-0002-4679-7137
Johannes von BürenWellster Healthtech Group, Munich, Germany.ORCID 0009-0001-5548-5450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: This narrative review examines the advantages and disadvantages of direct-to-consumer teledermatology for the treatment of male androgenetic alopecia, finding that this treatment modality improves access to care, ensures high adherence rates, and enhances patient satisfaction, while raising concerns about increased drug costs.

Indexed as

AlopeciaDermatologyTelemedicineHumansMalePatient Satisfactionandrogenetic alopeciadirect-to-consumerfinasteridemale pattern hair lossteledermatologytelemedicine

Identifiers

PMID41418299
PMCPMC12716827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.